MYM Announces Purchase of Greenhouses for Weedon, Quebec Project
Vancouver, B.C. / TheNewswire / May 18, 2018 – MYM Nutraceuticals Inc., (CSE: MYM) (the “Company” or “MYM”) is pleased to announce that CannaCanada Inc., in which MYM has a 93% ownership interest, has completed the purchase of the first round of greenhouses for the Weedon, Quebec project. The greenhouses are scheduled to be delivered by July 1, 2018.
“We are pleased to be another step closer towards completion of the Weedon project,” said Rob Gietl, CEO of MYM. “With the delivery of the first round of greenhouses scheduled for July 1, we anticipate having the first section of the project completed and ready for Health Canada inspection by the beginning of September, 2018.”
CannaCanada has finalized the hiring of LEED architect David Leslie. Mr. Leslie will oversee the erection of the greenhouses and general construction of the Weedon project with the goal of maximizing LEED certification points.
Terms have been agreed upon with general contractors ICORE for the project. ICORE is experienced in building ACMPR facilities in the province of Quebec. They will lead the construction of the entire project beginning immediately.
CannaCanada has purchased two buildings in downtown Weedon. One of the buildings will be renovated into accommodations for out of town contractors. The other building will be updated for offices and a community relations centre.
Joshua Tree Update:
Joshua Tree Brands Inc., is suspending production and sales of Hempmed, Dr. Furbaby, and Joshua Tree CBD products and related activities.
About MYM Nutraceuticals Inc.
MYM Nutraceuticals Inc. is an innovative company focused on acquiring Health Canada licenses to produce and sell high-end organic medicinal cannabis supplements and topical products. MYM has two production projects in Quebec that when completed will have over 1.5 million sf of production space. MYM is also a partner in a 1.2 million sf production project (Northern Rivers Project) in New South Wales, Australia. Australia is an exciting new market that has recently legalized medicinal cannabis. To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors. MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE: MYM) (OTC:MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).
ON BEHALF OF THE BOARD
Rob Gietl, CEO
MYM Nutraceuticals Inc.
Keep up to date with MYM on our social media channels:
This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.
This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), accepts responsibility for the adequacy or accuracy of this release.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities law and may not be offered or sold in the “United States”, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.